Migraine and tension-type headache treated with stromal vascular fraction: A case series

Journal of Medical Case Reports

Volumn 8, Issue 1, 2014, Pages

  Bright, Ralph ^a   Bright, Matthew ^a   Bright, Pelin ^a   Hayne, Shannon ^a   Thomas, Wayne D ^b  

^a Macquarie Stem Cells   (Australia)

^b Cell Innovations Pty Ltd   (Australia)

Author keywords

Headache; Mesenchymal stem cells; Migraine; Stromal vascular fraction; StroMed; SVF

Indexed keywords

ADRENALIN; BICARBONATE; COCODAMOL; CODEINE PHOSPHATE; DEXAMETHASONE; GROWTH FACTOR; LIDOCAINE; LORAZEPAM; METOCLOPRAMIDE; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; PETHIDINE; PLASMA RICH IN GROWTH FACTOR; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ARAB; ARTICLE; ASIAN; CASE REPORT; CASE STUDY; CELL FRACTIONATION; CELL THERAPY; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS ADMINISTRATION; MEDICAL HISTORY; PRIORITY JOURNAL; STROMA CELL; STROMAL VASCULAR FRACTION; TENSION HEADACHE; TRANSFORMED MIGRAINE; TREATMENT DURATION; TREATMENT OUTCOME; AUTOTRANSPLANTATION; CHRONIC DISEASE; CYTOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MIGRAINE DISORDERS; PROCEDURES; SUBCUTANEOUS FAT; TENSION-TYPE HEADACHE; TRANSPLANTATION;

ADULT; CHRONIC DISEASE; FEMALE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MIGRAINE DISORDERS; STROMAL CELLS; SUBCUTANEOUS FAT; TENSION-TYPE HEADACHE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84903329436     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-8-237     Document Type: Article

References (15)

1. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. Riordan NH, Ichim TE, Min WP, Wang H, Solano F, Lara F, Alfaro M, Rodriguez JP, Harman RJ, Patel AN, Murphy MP, Lee RR, Minev B, J Transl Med 2009 7 29 10.1186/1479-5876-7-29 19393041
2. Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety. Rodriguez JP, Murphy MP, Hong S, Madrigal M, March KL, Minev B, Harman RJ, Chen CS, Timmons RB, Marleau AM, Riordan NH, Int Arch Med 2012 5 5 10.1186/1755-7682-5-5 22313603
3. Pathophysiology of migraine. Pietrobon D, Moskowitz MA, Annu Rev Physiol 2013 75 365 391 10.1146/annurev-physiol-030212-183717 23190076
4. Central nervous system acting drugs in treatment of migraine headache. Samsam M, Cent Nerv Syst Agents Med Chem 2012 12 158 172 10.2174/ 187152412802430147 22533510
5. Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology. Bernstein C, Burstein R, J Clin Neurol 2012 8 89 99 10.3988/jcn.2012.8.2.89 22787491
6. Sensitization of meningeal sensory neurons and the origin of headaches. Strassman AM, Raymond SA, Burstein R, Nature 1996 384 560 564 10.1038/384560a0 8955268 (Pubitemid 26415932)
7. Response properties of dural nociceptors in relation to headache. Strassman AM, Levy D, J Neurophysiol 2006 95 1298 1306 10.1152/jn.01293.2005 16492942
8. Tension-type headache: current research and clinical management. Fumal A, Schoenen J, Lancet Neurol 2008 7 70 83 10.1016/S1474-4422(07)70325-3 18093564 (Pubitemid 350251941)
9. Concise review: endothelial stem and progenitor cells and their habitats. Goligorsky MS, Salven P, Stem Cells Transl Med 2013 2 499 504 10.5966/sctm.2013-0005 23761107
10. Mesenchymal stem cells in health and disease. Uccelli A, Moretta L, Pistoia V, Nat Rev Immunol 2008 8 726 736 10.1038/nri2395 19172693
11. New concepts on the immune modulation mediated by mesenchymal stem cells. Bunnell BA, Betancourt AM, Sullivan DE, Stem Cell Res Ther 2010 1 34 10.1186/scrt34 21092149
12. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Kim YJ, Park HJ, Lee G, Bang OY, Ahn YH, Joe E, Kim HO, Lee PH, Glia 2009 57 13 23 10.1002/glia.20731 18661552
13. Migraine as a systemic vasculopathy. Tietjen GE, Cephalalgia 2009 29 987 996 10.1111/j.1468-2982.2009.01937.x 19689607
14. Airway injury in lung disease pathophysiology: selective depletion of airway stem and progenitor cell pools potentiates lung inflammation and alveolar dysfunction. Reynolds SD, Giangreco A, Hong KU, McGrath KE, Ortiz LA, Stripp BR, Am J Physiol Lung Cell Mol Physiol 2004 287 1256 L1265 10.1152/ajplung. 00203.2004 15298853 (Pubitemid 39507205)
15. Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain. Guo W, Wang H, Zou S, Gu M, Watanabe M, Wei F, Dubner R, Huang GT, Ren K, Stem Cells 2011 29 1294 1303 10.1002/stem.667 21630378